| 創建日期 | 上市日期 | 董事長 | 總經理 |
|---|---|---|---|
| 76/09/18 | 93/01/07 | 翁維駿 | 周文智 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| 1.86(Q2) | 24.45 | 2.32 | 1.5% |
| 實收資本額 | 已發行普通股 | ||
| 1,075,086,340 | 107,508,634 | ||
| 主要經營業務 | |||
| 原料藥,原料藥中間體,特殊及精密化學品之加工,製造及銷售 | |||
| 公司網址 | |||
| sci-pharmtech.com.tw | |||
旭富(4119) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 98,813 | 124,845 | 52.2% | -20.9% | 818,641 | 543,878 | 50.5% |
| 2023/07 | 64,934 | 49,649 | 15.4% | 30.8% | 719,828 | 419,033 | 71.8% |
| 2023/06 | 56,260 | 60,923 | -57% | -7.7% | 654,894 | 369,384 | 77.3% |
| 2023/05 | 130,868 | 72,396 | 3.9% | 80.8% | 598,634 | 308,461 | 94.1% |
| 2023/04 | 125,987 | 48,043 | -12.1% | 162.2% | 467,766 | 236,066 | 98.2% |
| 2023/03 | 143,350 | 97,642 | 33.2% | 46.8% | 341,779 | 188,023 | 81.8% |
| 2023/02 | 107,645 | 26,959 | 18.6% | 299.3% | 198,430 | 90,381 | 119.5% |
| 2023/01 | 90,784 | 63,422 | 2.5% | 43.1% | 90,784 | 63,422 | 43.1% |
| 2022/12 | 88,585 | 39,412 | 45.8% | 124.8% | 899,738 | 864,217 | 4.1% |
| 2022/11 | 60,770 | 48,764 | -20.5% | 24.6% | 811,154 | 824,805 | -1.6% |
| 2022/10 | 76,411 | 47,590 | -41.3% | 60.6% | 750,384 | 776,042 | -3.3% |
| 2022/09 | 130,095 | 69,984 | 4.2% | 85.9% | 673,973 | 728,452 | -7.5% |
| 2022/08 | 124,845 | 65,351 | 151.4% | 91% | 543,878 | 658,468 | -17.4% |
| 2022/07 | 49,649 | 92,919 | -18.5% | -46.6% | 419,033 | 593,117 | -29.4% |
| 2022/06 | 60,923 | 62,243 | -15.8% | -2.1% | 369,384 | 500,198 | -26.1% |
| 2022/05 | 72,396 | 67,778 | 50.7% | 6.8% | 308,461 | 437,955 | -29.6% |
| 2022/04 | 48,043 | 46,551 | -50.8% | 3.2% | 236,066 | 370,177 | -36.2% |
| 2022/03 | 97,642 | 78,628 | 262.2% | 24.2% | 188,023 | 323,626 | -41.9% |
| 2022/02 | 26,959 | 117,932 | -57.5% | -77.1% | 90,381 | 244,998 | -63.1% |
| 2022/01 | 63,422 | 127,066 | 60.9% | -50.1% | 63,422 | 127,066 | -50.1% |
| 2021/12 | 39,412 | 78,498 | -19.2% | -49.8% | 864,217 | 2,689,222 | -67.9% |
| 2021/11 | 48,764 | 214,425 | 2.5% | -77.3% | 824,805 | 2,610,724 | -68.4% |
| 2021/10 | 47,590 | 205,214 | -32% | -76.8% | 776,042 | 2,396,299 | -67.6% |
| 2021/09 | 69,984 | 190,075 | 7.1% | -63.2% | 728,452 | 2,191,085 | -66.8% |
| 2021/08 | 65,351 | 200,510 | -29.7% | -67.4% | 658,468 | 2,001,010 | -67.1% |
| 2021/07 | 92,919 | 288,249 | 49.3% | -67.8% | 593,117 | 1,800,500 | -67.1% |
| 2021/06 | 62,243 | 169,230 | -8.2% | -63.2% | 500,198 | 1,512,250 | -66.9% |
| 2021/05 | 67,778 | 284,084 | 45.6% | -76.1% | 437,955 | 1,343,021 | -67.4% |
| 2021/04 | 46,551 | 274,608 | -40.8% | -83% | 370,177 | 1,058,936 | -65% |
| 2021/03 | 78,628 | 243,595 | -33.3% | -67.7% | 323,626 | 784,328 | -58.7% |
| 2021/02 | 117,932 | 237,366 | -7.2% | -50.3% | 244,998 | 540,733 | -54.7% |
| 2021/01 | 127,066 | 303,367 | 61.9% | -58.1% | 127,066 | 303,367 | -58.1% |
| 2020/12 | 78,498 | 146,778 | -63.4% | -46.5% | 2,689,222 | 2,355,747 | 14.1% |
| 2020/11 | 214,425 | 193,285 | 4.5% | 10.9% | 2,610,724 | 2,208,969 | 18.2% |
| 2020/10 | 205,214 | 179,896 | 8% | 14.1% | 2,396,299 | 2,015,684 | 18.9% |
| 2020/09 | 190,075 | 202,072 | -5.2% | -5.9% | 2,191,085 | 1,835,788 | 19.4% |
旭富(4119) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | -8.39% | 12.51% | 2020Q3 | -6.74% | 1.92% |
| 2023Q1 | 51.39% | 17.09% | 2020Q2 | -7.19% | 4.87% |
| 2022Q4 | -25.88% | 11.11% | 2020Q1 | 50.84% | 7.67% |
| 2022Q3 | 67.95% | 10.41% | 2019Q4 | -17.18% | 2.41% |
| 2022Q2 | -3.54% | 0.66% | 2019Q3 | 3.89% | 4.95% |
| 2022Q1 | 38.49% | -15.69% | 2019Q2 | 0.10% | 3.49% |
| 2021Q4 | -40.52% | -29.54% | 2019Q1 | 29.99% | 9.18% |
| 2021Q3 | 29.27% | -26.87% | 2018Q4 | -10.59% | 7.26% |
| 2021Q2 | -45.44% | -24.74% | 2018Q3 | -2.08% | 10.00% |
| 2021Q1 | -35.03% | -17.13% | 2018Q2 | 24.62% | 17.61% |
| 2020Q4 | -26.62% | -0.80% | 2018Q1 | 27.75% | 7.46% |
評論0